Alexa, What is Eliquis and Xarelto?
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 36
- 试验地点
- 2
- 主要终点
- % Change in pre- and post test scores
研究概览
简要总结
The purpose of this study is to evaluate the effectiveness of providing patient medication education about Eliquis and Xarelto through an Amazon Alexa based voice recording.
详细描述
Anticoagulants are considered high-risk medications due to the risk of major bleeding. The Federal Drug and Food Administration (FDA) MedWatch reporting system found that anticoagulants had the most adverse drug event (ADE) reports in 2011. Anticoagulants have also been reported as one of the leading drug classes contributing to emergency department visits3. Given the potential for serious adverse events, providing effective education to increase patient knowledge and awareness of those risks are essential. Incorporating technology into health care is becoming increasingly popular and has been shown to be effective for patient education. One reason is that technology can consistently provide complete patient education and is not subject to educator variability in providing this education.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Patients will be excluded if they have documented altered mental status, do not speak English, or are being prescribed rivaroxaban or apixaban on discharge only.
- •Nurses will be excluded if not providing direct patient care in select general medicine and orthopedic surgical units
- •Nurses declining participation
结局指标
主要结局
% Change in pre- and post test scores
时间窗: Within 72 hours of education
Effectiveness of Alexa based education by assessing understanding of Eliquis and Xarelto pre and post Alexa education
次要结局
- 7-day post-education retention rate(1 week post discharge)
- Patient satisfaction(72 hours)
- Nursing satisfaction(72 hours)
研究者
Kaman Chung
Pharmacy Manager
Cedars-Sinai Medical Center
